Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Market Pulse

Daily · Nov 5, 2026 · data.go.kr + ECOS

KOSPI

5,383.80

-300.00 (-5.28%)

KOSDAQ

678.41

-36.54 (-5.11%)

KOSPI 200

837.78

-51.47 (-5.79%)

USD/KRW

1,342.10

Home›Reports›326030

326030KOSPI·Feb 09, 2026

Strong 1Q26 earnings outlook vs. full-year cost pressures

SK BiopharmaceuticalsMirae Asset SecuritiesSeung-min Kim

Read original PDF ↗

SB

Source: Mirae Asset Securities
Type: Company Analysis
Language: English
Rating: Buy
Target price: -
Collected: May 06, 2026

The full report is published by Mirae Asset Securities. Korean Tickers provides its source link and metadata.

More research on 326030

Two concerns addressed; focus now turns to RISE3 dataMirae Asset Securities · Aug 27, 2026 Solid earnings; adding a second product could unlock further upsideMirae Asset Securities · Aug 07, 2026 Initiating Coverage: Xcopri’s Run; Securing New Growth Engines is NextKB Securities · May 27, 2026 Strong 2Q25 results ease concernsMirae Asset Securities · Aug 06, 2025 Concerns are overblownMirae Asset Securities · May 13, 2025 Leading the wayMirae Asset Securities · Feb 07, 2025

Advertisement

Korean Tickers·Research reference for Korean listed companies.

Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.

KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources

Terms Refunds Disclaimer Privacy